Dwight Evans, Representative
sell disclosed on 15 May 2026 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
CVS Health Corporation Common Stock (CVS)
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
30 disclosures
18 insiders
0 cluster signals
-1.6% avg. 30d outcome
Company facts
- Ticker / ISIN
- CVS / Not available
- Exchange
- Not available
- Country
- US
- Sector
- Not available
Related insiders
Adam Smith
Representative, 1 disclosure
Daniel Goldman
Representative, 3 disclosures
Dwight Evans
Representative, 3 disclosures
Earl Blumenauer
Representative, 1 disclosure
Gilbert Cisneros
Representative, 1 disclosure
James French Hill
Representative, 1 disclosure
Jefferson Shreve
Representative, 1 disclosure
John Rutherford
Representative, 1 disclosure
Julie Johnson
Representative, 2 disclosures
Kathy Manning
Representative, 1 disclosure
Lisa McClain
Representative, 3 disclosures
Rick Larsen
Representative, 1 disclosure
Rob Bresnahan
Representative, 2 disclosures
Thomas R. Suozzi
Representative, 1 disclosure
Thomas Suozzi
Representative, 3 disclosures
Valerie Hoyle
Representative, 2 disclosures
William R. Keating
Representative, 2 disclosures
Zoe Lofgren
Representative, 1 disclosure
Disclosure history
Dwight Evans, Representative
sell disclosed on 19 Dec 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Lisa McClain, Representative
sell disclosed on 21 Nov 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Lisa McClain, Representative
sell disclosed on 21 Nov 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Lisa McClain, Representative
buy disclosed on 21 Nov 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Valerie Hoyle, Representative
sell disclosed on 10 Oct 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Valerie Hoyle, Representative
buy disclosed on 12 Sept 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Adam Smith, Representative
sell disclosed on 8 Aug 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Jefferson Shreve, Representative
sell disclosed on 22 Jun 2025 via House STOCK Act disclosures
- Transaction value
- 15.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Rob Bresnahan, Representative
sell disclosed on 31 May 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Julie Johnson, Representative
sell disclosed on 14 May 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Rob Bresnahan, Representative
buy disclosed on 27 Mar 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Julie Johnson, Representative
sell disclosed on 12 Feb 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Gilbert Cisneros, Representative
buy disclosed on 11 Feb 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
James French Hill, Representative
sell disclosed on 4 Feb 2025 via House STOCK Act disclosures
- Transaction value
- 15.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Thomas R. Suozzi, Representative
sell disclosed on 12 Nov 2024 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -8.2%
Earl Blumenauer, Representative
sell disclosed on 6 Jul 2024 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
William R. Keating, Representative
sell disclosed on 22 May 2024 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +6.8%
Dwight Evans, Representative
buy disclosed on 5 Jul 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +5.6%
William R. Keating, Representative
sell disclosed on 15 Jun 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +2.4%
Zoe Lofgren, Representative
sell disclosed on 6 Jun 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -1.4%
Rick Larsen, Representative
sell disclosed on 26 May 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +3.3%
Daniel Goldman, Representative
sell disclosed on 19 May 2023 via House STOCK Act disclosures
- Transaction value
- 50.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -1.0%
Daniel Goldman, Representative
buy disclosed on 17 Apr 2023 via House STOCK Act disclosures
- Transaction value
- 15.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -7.7%
Daniel Goldman, Representative
buy disclosed on 24 Feb 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -14.2%
Thomas Suozzi, Representative
sell disclosed on 19 Dec 2022 via House STOCK Act disclosures
- Transaction value
- 15.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -7.2%
Thomas Suozzi, Representative
sell disclosed on 19 Dec 2022 via House STOCK Act disclosures
- Transaction value
- 15.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -7.2%
Thomas Suozzi, Representative
sell disclosed on 19 Dec 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -7.2%
Kathy Manning, Representative
buy disclosed on 10 Aug 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -1.8%
John Rutherford, Representative
sell disclosed on 19 Apr 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -9.9%